melanotic pigmentation of the sclera Pigmented Conjunctival Cancers (Primary Acquired Melanosis) » New York Eye Cancer Center Clinical appearances of complexion-related melanosis,

10.17179/excli2020-2866 EXCLI J

Typical Clinical Ranges Loading Phase: 25 mg per week (subcutaneous injection) for 46 weeks Maintenance Phase: 2 mg every 12 weeks after the loading period Key Considerations Personalization: Dosage should be adjusted based on individual symptoms, sensitivities, and treatment response

Lin A, et al

Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and survivin expression to potentiate ABT-263-induced apoptosis in non-small cell Lung cancer cells harboring EGFR or RAS mutation

Although less common for comprehensive profiling, ELISA can be used when focusing on particular acylcarnitines, such as acetylcarnitine or palmitoylcarnitine